LGVN News and Press, Longeveron Inc. From 06/17/21

Featuring Avalon GloboCare (AVCO), Caladrius Biosciences (CLBS), Celularity, ImmCelz / Creative Medical Technology Holdings (CELZ), ExoProTher, GID BIO, HealthLynked (HLYK), Longeveron (LGVN), Mesoblast (MESO) - Presented by Channelchek and Noble Capital Markets Read More >>

Longeveron CEO Geoff Green - The Investor Forum at the World Stem Cell Summit. Each presentation features a formal corporate overview, followed by a Q & A session moderated by a Noble Capital Markets equity research representative. Read More >>

MIAMI, June 15, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today that Geoff Green, Chief Executive Office...

Alzheimer’s disease (AD) is the most common cause of dementia, a progressively debilitating neurodegenerative disease that results in declining cognitive functions, inability to form new memories, behavioral disorders, and gradual loss of bodily functions. While older age does not cause...

MIAMI, June 10, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today that its Co-founder and Chairman, Joshua...

Recent advances in stem cell technologies, armed with the ability to generate almost any tissue-specific cell types of the body in a dish, human pluripotent stem cells (hPSCs) have drastically moved therapeutic research forward in unprecedented ways. Stem cell-derived cells are increasingly re...

Gainers: Annovis Bio (ANVS) +250%.Jiuzi Holdings (JZXN) +27%.Longeveron (LGVN) +25%.Wah Fu Education (WAFU) +22%.Mesa Royalty Trust (MTR) +20%.Gracell Biotechnologies (GRCL) +20%.Obalon Therapeutics (OBLN) +16%.Yalla Group (YALA) +16%.VOC Energy Trust (VOC) +12%.Cyclo Therapeut...

Gainers: Annovis Bio ANVS +112%, Gracell Biotechnologies (GRCL) +24%, Metacrine MTCR +16%, Sensei Biotherapeutics (SNSE) +14%, Longeveron (LGVN) +12%.Losers: Precipio (PRPO) -12%, Cullinan Oncology CGEM -8%, Navidea Biopharmaceutical...

MIAMI, May 18, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the hiring of Dan Gincel, Ph.D. as Senior V...

Longeveron Inc. (LGVN) Q1 2021 Earnings Conference Call May 14, 2021 8:30 AM ET Company Participants Brendan Payne – Stern Investor Relations Geoff Green – Chief Executive Officer James Clavijo – Chief Financial Officer Joshua Hare – Co-Founder, Chief Scientific Of...